4.3 Article

Nonalcoholic Fatty Liver Disease, Diabetes, Obesity, and Hepatocellular Carcinoma

Journal

CLINICS IN LIVER DISEASE
Volume 19, Issue 2, Pages 361-+

Publisher

W B SAUNDERS CO-ELSEVIER INC
DOI: 10.1016/j.cld.2015.01.012

Keywords

Nonalcoholic steatohepatitis; Cirrhosis; Noncirrhotic; Insulin resistance; Hepatocellular carcinoma; Obesity; Diabetes; Chemoprevention

Funding

  1. USC Research Center of Liver Diseases [P30 DK48522]

Ask authors/readers for more resources

Diabetes and obesity are associated with nonalcoholic fatty liver disease (NAFLD) and an increased incidence of hepatocellular carcinoma (HOC). NAFLD is the commonest cause of chronic liver disease. HOC can develop in NAFLD patients even without cirrhosis, suggesting an association between the metabolic process and HOC and raising a concern that many cancers could be missed given high NAFLD prevalence and screening limitations. The increasing prevalence of these conditions and lack of effective treatments necessitate a better understanding of their connection. This article defines the known interrelationships and common pathways between NAFLD, diabetes, obesity and HOC and possible chemoprevention strategies.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.3
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available